BioVie, Inc. (BIVI)
1.625
+0.02
(+0.93%)
USD |
NASDAQ |
Sep 21, 16:00
1.625
0.00 (0.00%)
After-Hours: 20:00
BioVie Price to Book Value : 1.193 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.182 |
| September 17, 2026 | 1.307 |
| September 16, 2026 | 1.263 |
| September 15, 2026 | 1.285 |
| September 14, 2026 | 1.506 |
| September 11, 2026 | 1.417 |
| September 10, 2026 | 1.403 |
| September 09, 2026 | 1.447 |
| September 08, 2026 | 1.520 |
| September 04, 2026 | 1.469 |
| September 03, 2026 | 1.491 |
| September 02, 2026 | 1.491 |
| September 01, 2026 | 1.645 |
| August 31, 2026 | 1.674 |
| August 28, 2026 | 1.586 |
| August 27, 2026 | 1.608 |
| August 26, 2026 | 1.550 |
| August 25, 2026 | 1.535 |
| August 24, 2026 | 1.572 |
| August 21, 2026 | 1.432 |
| August 20, 2026 | 1.366 |
| August 19, 2026 | 0.9841 |
| August 18, 2026 | 0.7083 |
| August 17, 2026 | 0.8593 |
| August 14, 2026 | 1.028 |
| Date | Value |
|---|---|
| August 13, 2026 | 1.146 |
| August 12, 2026 | 1.146 |
| August 11, 2026 | 0.9327 |
| August 10, 2026 | 0.8078 |
| August 07, 2026 | 0.7339 |
| August 06, 2026 | 0.9915 |
| August 05, 2026 | 1.498 |
| August 04, 2026 | 1.344 |
| August 03, 2026 | 1.190 |
| July 31, 2026 | 1.116 |
| July 30, 2026 | 1.050 |
| July 29, 2026 | 0.9254 |
| July 28, 2026 | 0.9768 |
| July 27, 2026 | 1.006 |
| July 24, 2026 | 1.006 |
| July 23, 2026 | 1.058 |
| July 22, 2026 | 0.9841 |
| July 21, 2026 | 0.9474 |
| July 20, 2026 | 1.046 |
| July 17, 2026 | 1.322 |
| July 16, 2026 | 1.263 |
| July 15, 2026 | 1.300 |
| July 14, 2026 | 1.160 |
| July 13, 2026 | 1.204 |
| July 10, 2026 | 1.667 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.20 |
| Anika Therapeutics, Inc. | 2.020 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.582 |
Price to Book Value Related Metrics
| Price | 1.625 |
| Earnings Yield | -196.8% |
| Market Cap | 12.26M |